CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 458414-458633 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T188","span":{"begin":0,"end":219},"obj":"Sentence"}],"text":"In DTC-carbapenem, its higher rate of mortality and relapse may relate to the patients' characteristics of more percentage of DM (45.7%), malignancy (45.7%), immunosuppression (42.9%), and nosocomial bacteremia (25.7%)."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T21446","span":{"begin":0,"end":219},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In DTC-carbapenem, its higher rate of mortality and relapse may relate to the patients' characteristics of more percentage of DM (45.7%), malignancy (45.7%), immunosuppression (42.9%), and nosocomial bacteremia (25.7%)."}

{"project":"Epistemic_Statements","denotations":[{"id":"T743","span":{"begin":0,"end":219},"obj":"Epistemic_statement"}],"text":"In DTC-carbapenem, its higher rate of mortality and relapse may relate to the patients' characteristics of more percentage of DM (45.7%), malignancy (45.7%), immunosuppression (42.9%), and nosocomial bacteremia (25.7%)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T998","span":{"begin":200,"end":210},"obj":"Phenotype"}],"attributes":[{"id":"A998","pred":"hp_id","subj":"T998","obj":"http://purl.obolibrary.org/obo/HP_0031864"}],"text":"In DTC-carbapenem, its higher rate of mortality and relapse may relate to the patients' characteristics of more percentage of DM (45.7%), malignancy (45.7%), immunosuppression (42.9%), and nosocomial bacteremia (25.7%)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2436","span":{"begin":126,"end":128},"obj":"Disease"},{"id":"T2438","span":{"begin":200,"end":210},"obj":"Disease"},{"id":"T21514","span":{"begin":126,"end":128},"obj":"Disease"},{"id":"T59008","span":{"begin":200,"end":210},"obj":"Disease"}],"attributes":[{"id":"A2436","pred":"mondo_id","subj":"T2436","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A2437","pred":"mondo_id","subj":"T2436","obj":"http://purl.obolibrary.org/obo/MONDO_0016367"},{"id":"A2438","pred":"mondo_id","subj":"T2438","obj":"http://purl.obolibrary.org/obo/MONDO_0005229"},{"id":"A51795","pred":"mondo_id","subj":"T21514","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A62134","pred":"mondo_id","subj":"T21514","obj":"http://purl.obolibrary.org/obo/MONDO_0016367"},{"id":"A98396","pred":"mondo_id","subj":"T59008","obj":"http://purl.obolibrary.org/obo/MONDO_0005229"}],"text":"In DTC-carbapenem, its higher rate of mortality and relapse may relate to the patients' characteristics of more percentage of DM (45.7%), malignancy (45.7%), immunosuppression (42.9%), and nosocomial bacteremia (25.7%)."}